BJDX Rasio bathi reged Bluejay Diagnostics Inc

Lambang korporat lan logo Bluejay Diagnostics Inc (BJDX)

Bluejay Diagnostics (BJDX) gross trading margin demonstrates a dependency on FDA approval, as commercial inflow is currently blocked by the testing stage. High pricing power in the critical diagnostics segment and a bedside rapid sepsis analysis strategy support the company's potential. The value of 0.00 shows the latest value of this indicator, which determines production efficiency and the financial stability of the business.

Tingkat bathi miturut bathi reged Bluejay (BJDX): kanggo periode 04.07.2022 - 19.11.2026

Rincian metrik keuangan lan pasar Bluejay Diagnostics, Inc. (BJDX)

- nilai saham lan prakiraan konsensus rega:
Produk sing diprodhuksi bluejaydx.com

The median gross margin on the GURU.Markets platform visualizes the efficiency of direct cost management, which is critical for assessing business scalability. This metric is calculated as the ratio of the difference between revenue and cost of goods sold to total sales, measuring the portion of funds available to cover operating expenses. For Bluejay Diagnostics (BJDX), which is currently in the FDA stage, the absence of operating income makes this metric an indicator of future risks upon the launch of rapid tests.

Pesaing langsung